Novo Nordisk reported DKK14.59B in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Bausch Health Companies USD 593M 0 Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Merck USD 3.86B 541M Mar/2026
Novartis USD 4.26B 64M Jun/2026
Novo Nordisk DKK 14.59B 212M Jun/2026
Novo Nordisk DKK 2.23B 131.82B Jun/2026
Pacira USD 17.51M 3.5M Jun/2026
Sanofi EUR 23.6B 888M Jun/2026
Supernus Pharmaceuticals USD 5.59M 4.58M Jun/2026